Archive for March, 2020

$SGLB Awarded Contract, PrintRite3D Real-Time Melt Pool Analytics at Northwestern University

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has been awarded a contract to implement its PrintRite3D Real-Time Melt Pool Analytics technology at Northwestern University. According to the update, Sigma Labs will integrate the PrintRite3D system to a DMG Mori LASERTEC12 Selective Laser Melting machine in collaboration with two university research centers at Northwestern University – Northwestern Initiative on Manufacturing Science and Innovation (“NIMSI”) and Center for Hierarchical Materials Design (“CHiMaD”). NIMSI researchers have developed computer-integrated systems for innovative subtractive, deformation-based and additive manufacturing processes. Sigma Labs and Northwestern will collaborate to further validate Sigma’s technology performance and capabilities to identify real-time defect formations during the printing process. “We are honored to have the opportunity to work with Northwestern University,” Sigma Labs Executive Chairman Mark Ruport said in the news release. “This type of collaboration is critical if additive manufacturing is to realize its potential and reach full industrialization.”

To view the full press release, visit http://nnw.fm/ZfOb0

About Sigma Labs

Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (“CAI”) solutions known as PrintRite3D(R) for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, March 3rd, 2020 Uncategorized Comments Off on $SGLB Awarded Contract, PrintRite3D Real-Time Melt Pool Analytics at Northwestern University

$GNPX to Present at the Third Annual LD Micro Virtual Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, today announced that it will present at the third annual LD Micro Virtual Conference at 1:40 p.m. EST on Wednesday, March 4. Genprex’s Chairman and Chief Executive Officer, Rodney Varner, will lead the company’s presentation and answer questions from investors. “We are delighted to be hosting our third virtual event in order to showcase some of the truly unique names in micro-cap,” LD Micro President Chris Lahiji said in the news release. “There are many people and companies who are unable to attend our live events due to any number of reasons, so we are happy to offer an additional way for companies to present to investors without taking a lot of time out of their day-to-day operations. While virtual events will never replace the experience of sitting in the same room as other humans, it is a great format for updating the investor community and getting increased exposure.”

To access the live presentation, visit http://nnw.fm/XiS1t

To view the full press release, visit http://nnw.fm/UEd2Y

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and other serious diseases who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches for patients with cancer and other serious diseases. The company’s lead product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (“NSCLC”), uses the company’s unique, proprietary platform which delivers cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. In January 2020, the FDA granted Fast Track Designation for Oncoprex in combination with AstraZeneca’s Tagrisso(R) for the treatment of NSCLC. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, March 3rd, 2020 Uncategorized Comments Off on $GNPX to Present at the Third Annual LD Micro Virtual Conference

$SGLB Becoming Standard for 3D-Printing QC Solutions?

March 2, 2020

  • On-demand 3D printing revolutionizing supply chain dynamics for manufacturing industry
  • SGLB is sole provider of urgently needed software solution that uniquely addresses in-process quality-control issues for 3D metal printing
  • Provision of quality-assurance software is valued at more than $1.4 billion, expected to grow to $3.9 billion by 2023

Referenced as one of tomorrow’s “greatest conduits for converting scarcity to abundance,” the 3D printing industry is transforming the $12 trillion manufacturing landscape while simultaneously disrupting the supply chain model (http://nnw.fm/yUi8A). At the frontline of the movement is Sigma Labs Inc. (NASDAQ: SGLB), the industry’s sole provider of quality-control software that puts more control of the 3D-printing metal process into the operator’s hands for the purpose of eliminating inefficiencies, reducing rejected output, and saving time and money.

Traditional metal machining manufacturers mostly carve, slice and grind away at raw materials to produce their products (called ‘subtractive manufacturing’) while the 3D metal printing process (also called additive manufacturing) creates objects by laser sintering powdered metals layer by 10-30 micron layer on top of each other using a computer-aided design (CAD) model and formed into the desired three dimensional object. Since the objects are built in layers, customizations are made by altering instructions in the digital file. Unfortunately, errors made during production are not found until after the process is complete, which results in excessive cost and material waste.

SGLB addresses this crucial issue through proprietary software solutions that enable operators to monitor the production process in real time and receive notifications about errors or anomalies while the process is taking place. This gives operators the knowledge required to make changes in real time, enabling them to avoid the creation of flawed output while producing yields of consistent high quality.

The demand for quality-control software increases as the production process becomes more complex. Two decades ago, 3D printers cost several hundred thousand dollars and used only plastic; today’s machines are 150 times faster and can print items using more than 500 different materials across the entire periodic table of elements.

While the first items printed were simple household items, before long, 3D printers were creating prosthetic limbs, rocket engines and car parts. However, as the uses for 3D printers increased, so also did quality-control challenges. The increased complexity of the production process demands better quality control, and SGLB has focused on software solutions for the industry. To date, SGLB has 19 beta programs in place with some of the largest names in industry – obtaining many tier-1 OEM enterprises such as GE Aviation, Honeywell and Airbus in the process.

Originally founded in 2010 by a team of Los Alamos National Labs scientists and engineers, SGLB first operated as a developer of commercially licensed, advanced metallurgical products. Forecasting high demand for quality-control solutions in the 3D-metal-printing space, the company shifted its operations to creating in-process quality-control software solutions for highly demanding, precision-dependent companies in the aerospace, defense, transportation, oil and gas, and biomedical industries.

The provision of quality-assurance software to the commercial, 3D-metal-printing industry is valued at over $1.4 billion and expected to explode to $3.9 billion by 2023. As the sole provider of innovative software solutions that address this demand, SGLB is likely to benefit from this unmet need while securing itself as a leader in what many are calling “the fourth industrial revolution.”

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, March 2nd, 2020 Uncategorized Comments Off on $SGLB Becoming Standard for 3D-Printing QC Solutions?

$RIV $CNPOF PharmHouse Receives Greenhouse-Wide Health Canada License

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its 49%-owned joint venture in Leamington, Ontario, PharmHouse Inc., received a license amendment from Health Canada allowing for cultivation across its entire greenhouse, which is now fully operational. According to the update, PharmHouse plans immediate ramp up in production in accordance with its offtake agreements with Canopy Growth Corporation and TerrAscend Canada Inc. Under these agreements, PharmHouse has committed 50% of its 2020 output and currently expects to use the remaining 50% of its capacity for both additional offtake agreements and its own private label brand. “The receipt of our license amendment represents a large milestone for PharmHouse,” PharmHouse General Manager Tony Abbas said in the news release. “This is a reflection of the hard work and dedication that our team has put in this past year and we are all very excited for this next chapter. Since the inception of PharmHouse, it has been our goal to bring innovation and consistency to greenhouse cannabis cultivation. With our full production capacity available to us and with the experience and market presence of our partners, we hope to change the industry concept of commercial cannabis production.”

To view the full press release, visit http://cnw.fm/RcP6i

About Canopy Rivers

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire portfolio. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Monday, March 2nd, 2020 Uncategorized Comments Off on $RIV $CNPOF PharmHouse Receives Greenhouse-Wide Health Canada License

$POAI Proposed Acquisition to Accelerate Discovery of New Anti-Cancers, Anti-Virals

Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today provided an update on its proposed acquisition of Carnegie Mellon University spin-out Quantitative Medicine. According to the update, this move further positions the company to aid in efforts to accelerate the discovery of new anti-cancers, anti-virals, antibiotics and vaccines. The acquisition will provide POAI with QM’s exclusively licensed, proven machine learning framework (“CoRE”), developed at CMU. CoRE, a predictive model-building platform for drug screening and optimization campaigns, uses hybrid machine learning approaches to rapidly build predictive models to drive wet lab experimentation. The CoRE approach united with POAI-Helomics division’s PDx tumor profiling platform and tumor data database allows for a one-of-a-kind, end-to-end “discovery machine” to cost-effectively and rapidly generate potential therapeutic candidates, which can be fast-tracked with demonstrated activity in preclinical laboratory tests. In projects with pharmaceutical companies, QM demonstrated that the CoRE platform could reduce time by 50% in the discovery of novel therapeutics. This “speed-to-patient” is important not only in cancer and other diseases but vital when searching for treatments or vaccines for a novel virus such as the coronavirus 2019-nCoV.

To view the full press release, visit http://nnw.fm/10jRP

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, March 2nd, 2020 Uncategorized Comments Off on $POAI Proposed Acquisition to Accelerate Discovery of New Anti-Cancers, Anti-Virals

$JMDA Platform Ecosystem to Solve Problems Inherent in Traditional Digital Media Models

March 2, 2020

  • Jerrick’s Vocal platform creates value for all stakeholders – creators, brands, and readers
  • Harvard Business Review article articulates why successful digital companies build virtuous cycles that solve problems
  • Vocal’s strategic virtuous cycle ecosystem increases value for all platform stakeholders

Using its exclusive platform for digital creators – Vocal – Jerrick Media Holdings Inc. (OTC: JMDA) has created a powerful virtuous cycle designed to support and reward creators, brands and readers alike. At the core of Jerrick’s virtuous cycle is the company’s commitment to and understanding of virtuous ecosystems, a concept that Harvard Business Review (http://nnw.fm/K44Jc) describes as “perhaps the single most important algorithmic distinction between ‘born digital’ enterprises and legacy companies… a clear real-time commitment to delivering accurate, actionable customer recommendations.”

“Recommendation engines (or recommenders) force organizations to fundamentally rethink how to get greater value from their data while creating greater value for their customers,” explained the HBR article, titled ‘Great Digital Companies Build Great Recommendation Engines’. Certainly, Jerrick’s Vocal platform fits the article’s analysis that “recommenders’ true genius comes from their opportunity to build virtuous business cycles: The more people use them, the more valuable they become; the more valuable they become, the more people use them.” Importantly, these so-called “recommendation engines” aren’t just about recommending products for consumers to buy – rather, this term refers to platforms that enable all types of digital interaction. “Appropriately designed,” the article explains, “these interactions create value for your customer and for you. Virtuous cycles can become more virtuous and valuable.”

In direct contrast to a vicious cycle, a virtuous cycle is a chain of events in which one desirable occurrence leads to another, further promoting the first occurrence and so on, resulting in a continuous process of improvement. Though the premise seems fundamental, many companies struggle with implementation. Jerrick’s Vocal platform, on the other hand, perfectly embodies the concept.

All three types of stakeholders involved in the Vocal platform – creators, brands and audiences – work synergistically throughout Vocal’s proprietary ecosystem, ensuring a balanced portfolio of revenue streams, sustainable infrastructures and compounding scalability.

To do this, Vocal provides creators with best-in-class tools, moderated communities and monetization opportunities. Vocal’s creators then leverage the platform to provide engaging content for readers across a huge range of subjects and communities; readers participate by giving creators feedback and support through tips and pledges. Creators also have the option to upgrade their free Vocal accounts to a paid Vocal+ premium subscription (first introduced in May 2019) for access a suite of exclusive value-added features, rewards and participation in exclusive Challenges (http://nnw.fm/LaJ6G).

In working with brands via their in-house creative studio Vocal for Brands, the Vocal team provides brand clients – which include DTC (direct-to-consumer) brands like Daily Harvest (http://nnw.fm/xUV6a) and Hims (http://nnw.fm/Hs77t) – with safety, insightful data and impressive conversions through bespoke paid branded content campaigns. Vocal pairs brands with already-established creators on their platform to tell the brand’s story in an authentic, engaging and non-interruptive way. Readers, then, provide brands with an engaged audience and valuable conversions.

Jerrick understands that the company succeeds when its partners – creators and brands – prosper. Consequently, the company is dedicated to creating scalable and equitable opportunities for all actors and platform stakeholders. “Virtuous cycles shouldn’t belong to customers alone,” the HBR article states, a principle Jerrick has embraced. “Wherever digitalization and data exist in abundance, the power and potential for recommenders shouldn’t be far behind. The best recommendation for enabling digital transformation is to enable the digital transformation of recommendation.”

This is exactly what Vocal’s Virtuous Cycle has done.

Jerrick Media Holdings is focused on the development of digital communities, targeted marketing of branded digital content and e-commerce opportunities. To accomplish these objectives, Jerrick envisions, designs and builds modern technology companies that redefine how people interact with technology. As the parent company of Vocal, Jerrick has built and shipped products that have influenced millions of people worldwide.

Those interested in weekly news from Jerrick can sign up at http://nnw.fm/hTp91

For more information, visit the company’s website at https://Jerrick.media

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://nnw.fm/JMDA

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, March 2nd, 2020 Uncategorized Comments Off on $JMDA Platform Ecosystem to Solve Problems Inherent in Traditional Digital Media Models
Next Entries »
TraderPower Featured Companies
Top Small Cap Market News
 

Recent Comments

    Archives